Radiolabeled Peptide Probes for Liver Cancer Imaging
- 8 December 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 27 (41) , 6968-6986
Abstract
Liver cancer/Hepatocellular Carcinoma (HCC) is a leading cause of cancer death and represents an important cause of mortality worldwide. Several biomarkers are overexpressed in liver cancer, such as Glypican 3 (GPC3) and Epidermal Growth Factor Receptor (EGFR). These biomarkers play important roles in the progression of tumors and could serve as imaging and therapeutic targets for this disease. Peptides with adequate stability, receptor binding properties, and biokinetic behavior have been intensively studied for liver cancer imaging. A great variety of them have been radiolabeled with clinically relevant radionuclides for liver cancer diagnosis, and many are promising imaging and therapeutic candidates for clinical translation. Herein, we summarize the advancement of radiolabeled peptides for the targeted imaging of liver cancer.Keywords
This publication has 140 references indexed in Scilit:
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like ParticlesACS Nano, 2011
- Glypican-3: A new target for cancer immunotherapyEuropean Journal of Cancer, 2011
- In Vitro and In Vivo Evaluation of 64 Cu-Radiolabeled KCCYSL Peptides for Targeting Epidermal Growth Factor Receptor-2 in Breast CarcinomasCancer Biotherapy and Radiopharmaceuticals, 2010
- From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathwayProceedings of the National Academy of Sciences, 2010
- Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancerCancer, 2009
- Molecular therapy for the treatment of hepatocellular carcinomaBritish Journal of Cancer, 2008
- Expression and mutational analysis of MET in human solid cancersGenes, Chromosomes and Cancer, 2008
- Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical ModelCancer Research, 2007
- The vascular endothelial growth factor receptor (VEGFR‐1) supports growth and survival of human breast carcinomaInternational Journal of Cancer, 2006